COMMUNIQUÉS West-GlobeNewswire

SteadyMed Provides Corporate Update and Reports Second Quarter 2018 Financial Results

14/08/2018 - 12:00

SAN RAMON, Calif., Aug. 14, 2018 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq: STDY), a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan and high-value diseases with [...]

TLC Doses First Patients in Phase I/II Trial of TLC590 for Postsurgical Pain Management

14/08/2018 - 10:55

TAIPEI, Taiwan and SOUTH SAN FRANCISCO, Calif., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Taiwan Liposome Company, Ltd. (4152.TWO; “TLC”), a clinical-stage specialty pharmaceutical company dedicated to the development and [...]

C-RAD has appointed Cecilia Danckwardt-Lillieström as new CFO

14/08/2018 - 09:00

C-RAD today announces that Cecilia Danckwardt-Lillieström has been appointed Chief Financial Officer effective October 15, 2018, succeeding Therése Björklund who will assume another position within the finance [...]

Reminder Invitation C-RAD Web Presentation Half-Year Report 2018

14/08/2018 - 08:30

Presentation of the report for the first half of the fiscal year 2018: Date: Friday August 17, 2018 / kl. 11:00 Venue: Online Presentation Topic: C-RAD Half-Year Report 2018 Procedure: Please register online through the [...]

Navamedic signs Sippi® agreement with Sweden's second largest county

14/08/2018 - 08:01

Navamedic ASA (OSE: NAVA), the Norwegian medtech and pharmaceutical products company, announced today that it has entered a contract with Västra Götalands Regionen (VGR) on its proprietary digital urinmeter Sippi®. VGR [...]

Shire plc : Rule 2.9 Announcement

14/08/2018 - 08:00

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 14 August 2018 [...]

Motif Bio Announces FDA Acceptance of New Drug Application with Priority Review for Iclaprim for Treatment of Acute Bacterial Skin and Skin Structure Infections

14/08/2018 - 08:00

PDUFA action date set for February 13, 2019 NEW YORK, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM/NASDAQ: MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today [...]

Curetis Announces Financial Results for the First Six Months of 2018

14/08/2018 - 07:39

Curetis Announces Financial Results for the First Six Months of 2018 - Successful U.S. launch of Unyvero System and LRT Application Cartridge, with strong pipeline of sales opportunities - Unyvero UTI Application [...]

Basilea reports half-year financial results reflecting strong in-market product sales growth in addition to progress and expansion of the R&D pipeline

14/08/2018 - 07:16

Total revenue increased by 30% to CHF 59.9 million; 2018 total revenue guidance is increased to CHF 120 - 130 million Royalties on Cresemba sales more than doubled to CHF 10.8 million Clinical oncology pipeline [...]

Curetis Announces Change in Curetis USA Inc. Management

14/08/2018 - 07:02

Curetis Announces Change in Curetis USA Inc. Management Christopher M. Bernard resigns as President & CEO of Curetis USA Inc. effective August 31, 2018 Chris D. Emery to succeed as President & CEO of Curetis USA [...]

Novartis appoints Dr. Klaus Moosmayer as Chief Ethics Risk and Compliance Officer

14/08/2018 - 07:01

Basel, August 14, 2018 - Novartis announced today the appointment of Dr Klaus Moosmayer as Chief Ethics, Risk and Compliance Officer. He will report to Vas Narasimhan, M.D., CEO of Novartis and become a member of the [...]

Merus annonce ses résultats financiers pour le deuxième trimestre 2018 et ses résultats d'exploitation intermédiaires

14/08/2018 - 04:53

Les données cliniques de la phase 1/2 de MCLA-128 tirées de la cohorte de patients atteints d'un cancer gastrique seront présentées à l'occasion du congrès de la Société européenne d'oncologie médicale (European Society [...]

Reviewed Financial Statement's announcement for the period 30 June 2018

13/08/2018 - 23:05

EASTPHARMA LTD. London, 13 August 2018 - EastPharma (EAST LI) announces that it is releasing its reviewed financial statements for the period 30 June 2018 and a review of its main subsidiary DEVA Holding's financial [...]

XBiotech présente une mise à jour trimestrielle de ses activités

13/08/2018 - 22:47

L'entreprise fournit une vue d'ensemble sur sa position financière et ses avancées dans les domaines clinique et de la recherche AUSTIN, Texas, 13 août 2018 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) a fourni une [...]

Allscripts open ecosystem drives healthcare data interoperability

13/08/2018 - 22:15

Global health IT leader enables more than four billion API data shares since 2013; applauds Microsoft and others’ joint commitment to help move healthcare towards the cloud CHICAGO, Aug. 13, 2018 (GLOBE NEWSWIRE) -- [...]

The Cooper Companies to Participate in the Baird Global Healthcare Conference

13/08/2018 - 22:15

PLEASANTON, Calif., Aug. 13, 2018 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO) will participate in the Baird 2018 Global Healthcare Conference in New York, NY, on September 5, 2018. Albert G. White III, [...]

Mustang Bio Reports Second Quarter 2018 Financial Results and Recent Corporate Highlights

13/08/2018 - 22:15

NEW YORK, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a Fortress Biotech (NASDAQ: FBIO) Company focused on the development of novel immunotherapies based on proprietary chimeric [...]

ImmuCell Announces Financial Results for Second Quarter of 2018

13/08/2018 - 22:05

PORTLAND, Maine, Aug. 13, 2018 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and [...]

Unum Therapeutics Announces Active Investigational New Drug (IND) Application for Antibody-Coupled T Cell Receptor (ACTR) platform in Combination with Trastuzumab in Patients with HER2+ Advanced Cancers

13/08/2018 - 22:05

– First Solid Tumor Product Candidate Based on Unum’s universal ACTR Technology – – Phase 1 Study Expected to Initiate by the End of 2018 – CAMBRIDGE, Mass., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. ( [...]